82 related articles for article (PubMed ID: 20587712)
1. New pathogenic candidates for diabetic macular edema detected by proteomic analysis.
Hernández C; García-Ramírez M; Colomé N; Villarroel M; Corraliza L; García-Pacual L; Casado J; Canals F; Simó R
Diabetes Care; 2010 Jul; 33(7):e92. PubMed ID: 20587712
[No Abstract] [Full Text] [Related]
2. Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis.
Hernández C; García-Ramírez M; Colomé N; Corraliza L; García-Pascual L; Casado J; Canals F; Simó R
Diabetes Metab Res Rev; 2013 Sep; 29(6):499-506. PubMed ID: 23568601
[TBL] [Abstract][Full Text] [Related]
3. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of vitreous from diabetic macular edema.
Ouchi M; West K; Crabb JW; Kinoshita S; Kamei M
Exp Eye Res; 2005 Aug; 81(2):176-82. PubMed ID: 16080911
[TBL] [Abstract][Full Text] [Related]
5. [Pathology of diabetic retinopathy].
Hata Y; Ishibashi T
Nihon Rinsho; 2005 Jun; 63 Suppl 6():165-70. PubMed ID: 15999701
[No Abstract] [Full Text] [Related]
6. Proteomics and diabetic retinopathy.
Merchant ML; Klein JB
Clin Lab Med; 2009 Mar; 29(1):139-49. PubMed ID: 19389556
[TBL] [Abstract][Full Text] [Related]
7. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy.
Patel JI; Saleh GM; Hykin PG; Gregor ZJ; Cree IA
Eye (Lond); 2008 Feb; 22(2):223-8. PubMed ID: 17001327
[TBL] [Abstract][Full Text] [Related]
8. Diabetic macular oedema and erythropoietin.
Uparkar M; Kaul S
Eye (Lond); 2009 Aug; 23(8):1747-8; author reply 748. PubMed ID: 19011603
[No Abstract] [Full Text] [Related]
9. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
[TBL] [Abstract][Full Text] [Related]
10. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy.
Lee CM; Olk RJ; Akduman L
Ophthalmic Surg Lasers; 2000; 31(4):292-300. PubMed ID: 10928666
[TBL] [Abstract][Full Text] [Related]
11. [Pitted optic papilla with fluorescein angiography-detected macular edema].
Köhler U
Klin Monbl Augenheilkd; 1988 Nov; 193(5):506-9. PubMed ID: 3210648
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema.
Hernández C; Fonollosa A; García-Ramírez M; Higuera M; Catalán R; Miralles A; García-Arumí J; Simó R
Diabetes Care; 2006 Sep; 29(9):2028-33. PubMed ID: 16936148
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema.
Bolz M; Schmidt-Erfurth U; Deak G; Mylonas G; Kriechbaum K; Scholda C;
Ophthalmology; 2009 May; 116(5):914-20. PubMed ID: 19410950
[TBL] [Abstract][Full Text] [Related]
14. [Results of laser photocoagulation in diabetic retinopathy with maculopathy].
Palacz O; Sylwestrzak Z; Oszczyk U
Klin Oczna; 1991; 93(10-11):306-7. PubMed ID: 1726495
[TBL] [Abstract][Full Text] [Related]
15. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema.
Kang SW; Park CY; Ham DI
Am J Ophthalmol; 2004 Feb; 137(2):313-22. PubMed ID: 14962423
[TBL] [Abstract][Full Text] [Related]
16. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
Sander B; Larsen M; Moldow B; Lund-Andersen H
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema.
Schaudig UH; Glaefke C; Scholz F; Richard G
Ophthalmic Surg Lasers; 2000; 31(3):182-6. PubMed ID: 10847492
[TBL] [Abstract][Full Text] [Related]
18. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes.
Awata T; Kurihara S; Takata N; Neda T; Iizuka H; Ohkubo T; Osaki M; Watanabe M; Nakashima Y; Inukai K; Inoue I; Kawasaki I; Mori K; Yoneya S; Katayama S
Biochem Biophys Res Commun; 2005 Aug; 333(3):679-85. PubMed ID: 15963467
[TBL] [Abstract][Full Text] [Related]
19. How does vitrectomy affect diabetic macular edema?
Stefánsson E; Landers MB
Am J Ophthalmol; 2006 May; 141(5):984; author reply 984-5. PubMed ID: 16678538
[No Abstract] [Full Text] [Related]
20. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
